Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications

MRI contrast agents containing the rare earth metal gadolinium are very effective, yet unstable and thus potentially hazardous. Here, the authors developed complexes between gadolinium and the scaffolding compound DOTA with increased stability, which also lend themselves to radiometal labelling.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lixiong Dai, Chloe M. Jones, Wesley Ting Kwok Chan, Tiffany A. Pham, Xiaoxi Ling, Eric M. Gale, Nicholas J. Rotile, William Chi-Shing Tai, Carolyn J. Anderson, Peter Caravan, Ga-Lai Law
Format: article
Langue:EN
Publié: Nature Portfolio 2018
Sujets:
Q
Accès en ligne:https://doaj.org/article/b3f0ee3971b54efaad568f148589af0b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!